Associate Director, Marketing Content Enablement Lead

USA (On-site)

Salary Not AvailableSenior Level7+ years expFull time

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive accelerated, compliant pharmaceutical marketing content creation and launch operations for oncology with cross-functional and agency partnerships.

  • Own modernization of promotional content processes and scalable workflows
  • Must-have: 7-8+ years of pharma marketing with experience managing complex operations and systems (e.g. Veeva)
  • Standout: Cross-functional collaboration with Sales, Medical, Regulatory, and external agencies to pilot scalable content solutions

Job Description

Responsibilities

  • Spearhead initiatives to modernize promotional content creation processes, improving efficiency and scalability
  • Lead the implementation of tools to support promotional content generation, modular content development, and workflow optimization
  • Establish best practices for marketing content creation in a compliant, regulated environment
  • Work closely with Omnichannel team to generate content to enable seamless orchestrations across audiences
  • Accelerate speed-to-market of marketing materials
  • Own execution of variety of HCP, APP, and Patient-facing materials
  • Partner with internal teams and external agencies to pilot and scale innovative content solutions
  • Translate brand strategy into actionable, audience-specific campaigns that drive engagement and measurable outcomes
  • Partner with cross-functional stakeholders (e.g., Sales, Medical, Market Access, Regulatory, Legal) to ensure strategically-aligned and compliant execution
  • Serve as a critical input to strategic evolution workstreams (e.g. brand planning)

Requirements

  • Bachelors Degree required in related field or equivalent experience
  • 7-8+ years of pharmaceutical experience in US or global marketing (industry or agency)
  • 5+ years Brand Management experience (industry or agency)
  • US marketing experience in oncology, lung experience preferred
  • Recent launch experience required
  • Proven experience managing complex marketing operations processes (Promotional Material Review, Brand Planning, Market Research, CRM Management etc.) and systems (e.g. Veeva)
  • Hands-on approach to content development
  • Deep understanding of marketing campaign management, day-to-day execution, measurement and tracking
  • Possess the ability and desire to measure and track performance and success of programs/initiatives
  • Excellent interpersonal relationship skills including negotiating and relationship management skills with ability to drive achievement of objectives

Preferred

  • Experience with AI tools preferred

Benefits

  • Competitive Base Salary, Bonus, and Equity Plans
  • Unlimited Vacation and 10 Sick Days Annually
  • Excellent Medical, Dental, and Vision Coverage
  • 401K with Company Matching
  • and much more!
Nuvation Bio logo

Nuvation Bio

4.7 Glassdoor

Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.

Founded in 2018
New York, New York, USA
220 employees (17 in marketing)
100% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
21.8K
Monthly Google Ads Budget
$13.2K
Traffic Source Mix
Search
39%
Direct
44%
Referral
5.1%
Social
9.8%
Paid
2%

Headcount Trend

Current headcount: ~220

Marketing Team

Marketing Team Size
16 (7% of company)

Funding

Total Funding
$927M
Last Raise
$150M
Post IPO Debt, 1 years ago

Funding History

  • Mar 2025
    Post IPO Debt • $150M
  • Feb 2021
    Post IPO Equity • $502M
  • Oct 2019
    Series A • $275M

Recent News